Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.
Important Notice to Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Manhattan Associates, Inc. (NASDAQ: MANH); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is…
GlobeNewswire, Inc.
·
July 10, 2025
PHILADELPHIA, July 10, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI): Current Methode Electronics, Inc. (NYSE: MEI) shareholders who have held Methode Electronics shares since prior to June 23, 2022, can seek corporate reforms,...
Brookdale and Monmouth Medical Center Launch Partnership to Expand Nursing Education and Workforce Pathways
GlobeNewswire, Inc.
·
July 10, 2025
Lincroft, NJ, July 10, 2025 (GLOBE NEWSWIRE) -- Brookdale Community College and Monmouth Medical Center (MMC) have entered into an agreement to expand educational and career opportunities for aspiring nurses in Monmouth County. The formal...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive...
Nicholas Licausi’s 'The Medical Project' Explores a Fictional Mission to Reform a Flawed Healthcare System
EIN Presswire
·
July 10, 2025
A technology-driven thriller inspired by personal loss and a desire to improve the way medical care is delivered. YORBA LINDA, CA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- In “The Medical Project,” author Nicholas Licausi blends...
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or...
Jase Medical Launches Jase Pantry: 30-Day Emergency Food Supply Packed with High Calories and Protein
EIN Presswire
·
July 10, 2025
Jase Pantry reflects the company’s expanded mission: to help people prepare for the unexpected by securing all 3 survival essentials—food, water, and medicine SALT LAKE CITY, UT, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Jase Medical,...
Governor Ivey Announces Medicaid Commissioner Stephanie Azar to Chair State Employees’ Insurance Board, Appoints Bo Offord as Agency Commissioner
Office of Alabama Governor
·
July 10, 2025
MONTGOMERY – Governor Kay Ivey on Thursday announced she will appoint Bo Offord to serve as commissioner of the Alabama Medicaid Agency. Stephanie McGee Azar, after leading the Medicaid Agency for over 13 years, will become the chief executive...
SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire, Inc.
·
July 10, 2025
DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life,...
Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
GlobeNewswire, Inc.
·
July 10, 2025
New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight Interleukin-2 (IL-2) inhibitors are immunosuppressive...
Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire, Inc.
·
July 10, 2025
New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The cannabinoid agonist market is gaining...
Mission Mobile Medical Group Launches Executive-in-Residence Program; David B. Vliet Named to Inaugural Cohort
EIN Presswire
·
July 10, 2025
The Executive-in-Residence Program to transform rural healthcare access by accelerating the improvement in Quality measures for Medicaid populations for MCOs GREENSBORO, NC, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Accelerating the...
UltraSight™ Appoints New Medical Advisory Board Members to Lead Clinical Plan for Machine Learning Cardiac Ultrasound
EIN Presswire
·
July 10, 2025
Three Leading Physicians Join Medical Advisory Board to Advance Clinical Strategy and Drive Adoption of Machine Learning Point‑of‑Care Cardiac Ultrasound BOSTON, MA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- UltraSight™, a digital...
IBCCES Certifies Surprise Fire-Medical Department as a Certified Autism Center™, Enhances Community Support
EIN Presswire
·
July 10, 2025
SURPRISE, AZ, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- The International Board of Credentialing and Continuing Education Standards (IBCCES) awards the Certified Autism Center™ (CAC) to the Surprise Fire-Medical Department. To earn this...
9 Medicaid Providers Indicted on Fraud Charges
Ohio Attorney General
·
July 10, 2025
(COLUMBUS, Ohio) — In indictments filed this week by the office of Ohio Attorney General Dave Yost, nine Medicaid providers are accused of stealing a combined $1.2 million from the government health-care program for the needy. Eight home-health...
Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL
GlobeNewswire, Inc.
·
July 10, 2025
ROCKVILLE, Md. and SUZHOU, China, July 10, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that its proprietary novel Bcl-2...
Medical Supplierz Announces Strategic Partnerships with Leading Healthcare Brands
EIN Presswire
·
July 10, 2025
KUWAIT, KUWAIT, July 10, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B marketplace for medical equipment and supplies, has announced new partnerships with a select group of leading healthcare brands. These collaborations aim to...
Amplity Rebrand Recognized: A New Approach To Pharma Outsourcing Services
EIN Presswire
·
July 10, 2025
LANGHORNE, PA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Amplity, a full-service partner for outsourcing flexible medical and commercial services, is honored to be named a Titan and GDUSA awardee for its comprehensive rebrand work...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT). Such investors are advised to contact Danielle Peyton at...
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
GlobeNewswire, Inc.
·
July 10, 2025
BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral presentation at the 9th International Calicivirus...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton...